Crewe Advisors’s Rentokil RTO Stock Holding History

Crewe Advisors’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-338	Closed	-$10K	–	945
2024 Q2	$10K	Buy	338 +311	+1,152%	+$8.63K	﹤0.01%	692
2024 Q1	$815	Buy	+27	New	+$749	﹤0.01%	893

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Crewe Advisors's RTO Position: Q3 2024 in Review

Crewe Advisors sold out of Rentokil (RTO) in Q3 2024, closing a stake of 338 shares — an estimated $10K sold.

Crewe Advisors first reported a position in RTO in Q1 2024 and held it in 2 quarters. The position peaked at $10K in Q2 2024. 220 funds tracked by Wall St. Rank hold RTO as of Q3 2024.

Crewe Advisors reported no remaining Rentokil position as of Q3 2024 after selling out during the quarter.
Crewe Advisors sold 338 Rentokil shares in Q3 2024, an estimated $10K.
Crewe Advisors first reported a position in Rentokil in Q1 2024 and held it in 2 quarters.
Crewe Advisors's Rentokil position peaked at $10K in Q2 2024.
220 funds tracked by Wall St. Rank held Rentokil as of Q3 2024.

Based on Crewe Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.